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A B S T R A C T
Background: Pathologist evaluation of donor liver biopsies provides information for accepting or discarding
potential donor livers. Due to the urgent nature of the decision process, this is regularly performed using fro-
zen sectioning at the time of biopsy. The percent steatosis in a donor liver biopsy correlates with transplant
outcome, however there is significant inter- and intra-observer variability in quantifying steatosis, com-
pounded by frozen section artifact. We hypothesized that a deep learning model could identify and quantify
steatosis in donor liver biopsies.
Methods: We developed a deep learning convolutional neural network that generates a steatosis probability
map from an input whole slide image (WSI) of a hematoxylin and eosin-stained frozen section, and subse-
quently calculates the percent steatosis. Ninety-six WSI of frozen donor liver sections from our transplant
pathology service were annotated for steatosis and used to train (n = 30 WSI) and test (n = 66 WSI) the deep
learning model.
Findings: The model had good correlation and agreement with the annotation in both the training set (r of
0.88, intraclass correlation coefficient [ICC] of 0.88) and novel input test sets (r = 0.85 and ICC=0.85). These
measurements were superior to the estimates of the on-service pathologist at the time of initial evaluation
(r = 0.52 and ICC=0.52 for the training set, and r = 0.74 and ICC=0.72 for the test set).
Interpretation: Use of this deep learning algorithm could be incorporated into routine pathology workflows
for fast, accurate, and reproducible donor liver evaluation.
Funding:Mid-America Transplant Society











There is a global shortage of donor livers suitable for transplanta-
tion. In the United States alone, approximately 11,000 people are
added to the wait list for liver transplant every year, yet nearly 10% of
livers recovered for transplant are discarded [1]. The decision to dis-
card may be made after histologic examination of biopsies from
potential donor livers, which is essential to assess organ suitability
prior to transplantation, and to provide predictive information for
graft outcome [24]. This evaluation must be performed quickly,
since increased warm and cold ischemic time are associated with
poor graft outcome [58]. Warm ischemic time occurs in donation
after circulatory death donors, as the organ remains in the body after
the blood supply has been reduced, while cold ischemic time is the
time from cross-clamping of the donor liver to removal of the liver
from cold storage solution [7,9].
One of the most important features to evaluate is the percentage
of macrovesicular steatosis (herein referred to as steatosis). While
some non-invasive methods have been proposed [1012], the gold
standard for steatosis evaluation remains liver biopsy and examina-
tion by a pathologist [13]. Using histologic assessment of steatosis,
some studies have suggested that transplantation of donor livers
with 30% macrovesicular steatosis is associated with early allograft
dysfunction, with conflicting evidence regarding the definitions and
role of small versus large droplet macrovesicular steatosis [3,1421].
However, there is no agreed-upon cutoff value for discarding donor
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livers and in some centers, livers with reportedly much greater than
30% steatosis are successfully transplanted [2224]. Part of the prob-
lem with defining thresholds for steatosis evaluation in donor liver
biopsies may be the significant variability that exists between observ-
ers, with reported correlation coefficients widely ranging from
0.550.98 (continuous percentages), and kappa values ranging from
0.380.94 (categorical grades) [2530]. Furthermore, due to the time-
sensitive nature of donor liver evaluation, pathologists currently man-
ually identify and make visual estimates of features of biopsies
prepared by rapid intra-operative frozen sectioning, a process that is
known to contain histologic artifacts that can mimic steatosis (water
droplets, holes, etc.) [31]. Comparison to the corresponding formalin-
fixed, paraffin-embedded (FFPE) sections can reveal these artifacts.
Studies show that agreement between estimates of steatosis in frozen
sections versus properly fixed and processed permanent sections is
less than 70% [31,32]. In addition, the concordance rate of estimation
of percent steatosis between nonspecialist pathologists and expert
liver pathologists is only 70% [32]. Inaccurate assessment of steatosis
could lead to unnecessary discard and longer transplant wait list time
(if overestimated), or poor transplant outcome (if underestimated).
Therefore, approaches to standardize the quantification process with
rapid, accurate, and reproducible interpretation of steatosis on donor
liver biopsies will enhance decision-making for transplant clinicians.
Recently, deep learning, a subset of machine learning, has revolu-
tionized several fields, including medical image analysis, and pro-
vides a possible solution for accurate frozen section steatosis
quantification [33]. In particular, deep learning convolutional neural
networks (CNNs) have been shown to perform as well as human
experts in solving many image recognition tasks, including those spe-
cific to anatomic pathology. For example, deep learning algorithms
can be employed to automate grading of prostate biopsies, classify
melanoma, recognize patterns of lung adenocarcinoma, and detect
breast cancer lymph node metastases [3439]. These deep learning
CNNs are modeled after neural networks, with multiple connected
layers that process the data and transmit the output to the next layer.
CNNs for image analysis are trained on input images, and the models
automatically learn salient features from the data alone. We therefore
hypothesized that a deep learning algorithm would be able to deter-
mine steatosis on frozen sections as well as expert liver pathologists.
Here, we describe the development of a deep learning model that
can accurately and reproducibly interpret percent macrovesicular
steatosis onWSI of donor liver biopsy frozen sections within minutes.
Our work advances the field of deep learning-based computer-aided
diagnosis by the use of intraoperative frozen sections, for which there
are few published studies [40,41], and by applying classification and
quantification methods to a critical problem in surgical pathology
and transplantation.
Materials and methods
Case selection and cohorts
H&E-stained frozen donor liver biopsies were obtained from cases
evaluated between April 2015 and December 2016 by the Washington
University School of Medicine Transplant Pathology service, which
evaluates donor liver biopsies from multiple organ procurement
organizations. During this time, all frozen sections were digitally
scanned into WSI. 96 total cases from 91 deceased donors were
selected to exhibit a wide range of percent steatosis values (<1% to
>95%; Table 1 and Supplemental Table 1). The sample size was deter-
mined by the number of available WSI at the time of initial evaluation.
Cases with poor image quality were excluded. Cases were selected
based on steatosis values alone, determined by the on-service patholo-
gist, without looking at the WSI. 5 donors were the source of 2 frozen
sections each  these were treated as independent samples as they
were prepared and evaluated separately. 44 of the donors were female,
and 47 of the donors were male. For training and testing the deep
learning algorithm, the cases were randomly divided into an anno-
tated training set (n = 30), and an annotated test set (n = 66).
Evaluation of steatosis
Each WSI underwent 5 evaluations: the initial interpretation by
the on-service pathology (OS-P) at the time of transplant evaluation,
re-review by 3 pathologists, and assessment by the deep learning
Research in Context
Evidence before this study
We searched PubMed and Google Scholar databases for peer-
reviewed, original research articles and reviews from 1990 to
2020, using combinations of search terms in three areas of
interest: 1) value of hepatic steatosis estimation in transplant
(“hepatic or liver transplant steatosis outcomes”, “steatosis
estimation frozen,” “liver transplant evaluation”); 2) patholo-
gist estimation of hepatic steatosis (“pathologist estimation
hepatic or liver steatosis”, “pathologist agreement steatosis,”
“variability pathologist steatosis”); and 3) computational
assessment of steatosis (“computational assessment steatosis
histology,” “artificial intelligence steatosis,” “computer quanti-
fication steatosis”).
We found that the majority of articles agreed that high
amounts of macrovesicular steatosis correlated with poor graft
outcome, although the threshold for recommended organ dis-
card varied by study and center. One review highlighted the
increasing number of steatotic liver grafts due to the expanding
prevalence of fatty liver disease, and how the lack of a reliable
method for steatosis quantification contributes to an inconsis-
tent ability to predict graft outcome. Multiple studies measur-
ing intra- and inter-observer variability illustrated that there is
poor agreement among pathologists in the quantification of
hepatic macrovesicular steatosis. In addition, studies have dem-
onstrated the difficulty and error rate of pathologist evaluation
of steatosis in frozen sections specifically, which are used in
donor liver assessment due to their rapid preparation, but are
subject to substantial artifact. Previous attempts to computa-
tionally quantify steatosis in histologic images involved mea-
surement of the fraction of the image area occupied by fat
droplets, many using segmentation methods focussing on
white space quantification. We found only one method that
attempted to quantify steatosis in frozen section slides, and it
used Oil Red O staining to highlight fatty areas.
Added value of this study
Our project directly addresses the problem of the lack of a reli-
able method for steatosis quantification by developing a deep
learning model that can accurately and reproducibly quantify
liver steatosis. In addition, it performs on digitized frozen sec-
tion slides, accounting for confounding frozen section artifact.
Our model performs the analysis and quantification within
minutes, much faster than many whole-slide imaging deep
learning models.
Implications of all the available evidence
Donor liver macrovesicular steatosis correlates with graft out-
come. Accurate quantification of this steatosis by automated
deep learning models could aid in predicting transplant out-
come and help prevent unnecessary donor organ discard.
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model. Frozen sections of the donor liver biopsies were initially eval-
uated by the 24hr on-service pathologist, as part of routine clinical
practice, and percent steatosis was recorded as part of the initial
report. All on-service pathologists were surgical pathologists with or
without liver pathology expertise. The frozen WSI were re-reviewed
by two expert liver pathologists and a pathology trainee, who also
reviewed permanent sections of the frozen liver biopsy remnants, as
an “optimized” pathologist assessment. The purpose of reviewing the
FFPE permanent sections was to account for frozen section artifact.
These assessments were recorded as percentages in 5% increments. If
a range of steatosis was reported by any pathologist, the average of
the range was used in comparative analyses. Re-reviewers were
blinded to the initial on-service pathologist percentage, as well as to
other evaluator assessments. The average of the percent steatosis
determined by the 3 pathologists after evaluation of both frozen
section WSI and permanent sections was recorded as the average
re-reviewer assessment.
Whole slide imaging
Frozen sections were scanned at 20X using an Aperio Scanscope
CS2 scanner (Leica Biosystems, Wetzlar, Germany) and stored in SVS
format, then converted to TIFF format at full resolution (0.495 mm/
pixel).
Annotation
Areas of steatosis were manually annotated in series by two path-
ologists (initial annotation by a pathology trainee, followed by review
by an expert liver pathologist). Annotation was performed by outlin-
ing and labeling all areas of macrovesicular steatosis (using ellipti-
cally-shaped and free-form masks) in each WSI using an in-house
plugin written for Fiji [41,42], generating pixel-wise label masks of
steatotic regions at the same resolution as the parent WSI. To account
for frozen section artifact, artifactual white areas that were present in
the frozen section WSI, but not in the FFPE permanent slides, were
not labeled. All cells with macrovesicular steatosis were annotated
(including large droplets with large vacuoles in the cytoplasm with
eccentric nuclear displacement, and small droplets with few/discrete
fat vacuoles without nuclear displacement) [21,43]. Microvesicular
steatosis was defined as the presence of non-zonal, contiguous
patches of foamy hepatocytes and was not included in the annota-
tion, as current evidence does not support its clinical utility in donor
liver evaluation [44,45]. Adjacent nuclei and cytoplasm of steatotic
hepatocytes were included in the annotation masks to provide addi-
tional context for the deep learning model. For some larger images
with higher percentages of steatosis, representative bounding box
areas were annotated instead of the whole slide. This enabled train-
ing on more images to account for differences in slide cutting and
staining variables. Bounding box areas were selected to include at
least 2 portal tracts and intervening areas, as well as zones with fro-
zen artifact. Areas with tissue folding were not included. For the
training set of 30 WSI, 19 had bounding boxes and 11 were
completely annotated. For the test set, 33/66 had bounding boxes.
10,653 regions (containing one or more steatotic cells) were labeled
and used to generate 75,079,680 target pixels from 30 WSI for train-
ing the CNN. For the test set, 12,643 annotation regions comprising
113,626,112 pixels were labeled. Because the CNN output was down-
sampled 32x relative to the input images, the annotation masks were
similarly downsampled to maintain pixelwise registration. Down-
sampling was accomplished by gridding the full-size annotation
mask into 32 £ 32 pixel patches and assigning to the corresponding
target pixel the fraction of the original patch area covered by the
mask.
CNN architecture
Utilizing a pre-trained network as a starting point (that is, transfer
learning) has been shown to be a useful technique to reduce the need
for large training datasets and decrease training time for deep CNNs
[46,47]. In transfer learning, the hundreds of millions of network
weights in the deep layers of the model (which encode generic image
features) are kept constant, while the weights of the uppermost clas-
sification layers are allowed to change in the process of training in
the new domain. Thus, a much smaller set of network weights needs
to be optimized for model convergence, which is therefore feasible
with fewer computational resources and input images. We trained a
fully convolutional model based on VGG16, a CNN originally trained
(using a vast amount of computational time and resources) on a large
database of millions of digital photographs to label image content
[48]. No image preprocessing was performed prior to training or test-
ing, other than that prescribed in the VGG16 schema, i.e., subtraction
by a precomputed fixed RGB value [48]. Starting with the pre-trained
VGG16 CNN with weights frozen below the bottleneck, we replaced
the final fully-connected layers with the following sequence of con-
volutional layers: two 1 £ 1 convolution layers (256 and 128 nodes,
respectively), followed by a 64-node 3 £ 3 convolution layer and
another 64-node 5 £ 5 convolutional layer (Fig. 3). All convolutional
layers used ReLU activation, with no input padding before filtering.
Output was fed to a 2-node layer with softmax activation for classifi-
cation into steatotic and non-steatotic categories.
Storing the activations of a fully convolutional network over an
entire WSI is not feasible due to excessive memory requirements,
therefore we adopted a sampling approach to training the model. For
images used in training and validation, 832 £ 832-pixel partially-
overlapping image patches (stride=448) having at least 5% non-back-
ground area were extracted and presented to the model by weighted
sampling. Classes were weighted in a ratio of 4:1 for steatosis:back-
ground categories to account for class imbalance.
The task of the CNN was to assign labels to individual pixels in the
WSI to match the provided annotations. Because the model's output
was downsampled by a factor of 32 relative to the original image, the
CNN was trained against a similarly downsampled annotation map,
by computing the ratio of the number of annotation mask pixels to
total pixel number within each cell of a 26 £ 26 pixel grid in the full-
size annotation mask.
The fully convolutional CNN was trained in several phases in
which successively deeper convolution block weights were unfrozen
and allowed to be modified in training. In the first phase, the pre-
trained VGG16 layers up to the bottleneck were frozen and the top
layers were trained for 15 epochs using the Adam optimizer with a
learning rate of 1e-4 [49]. In the next phase, the weights from the last
convolutional block (composed of 3 convolutional layers) before the
bottleneck were then unfrozen, and the model trained for 5 epochs
using stochastic gradient descent (SGD) with a learning rate of 1e-5.
This was repeated twice more, each time unfreezing the next deeper
convolutional block for training. The final phase entailed unfreezing
all model weights and training for 15 epochs. Training in phases as
described, with low learning rates and SGD optimizer, was necessary
to prevent overfitting and training loss divergence as the model’s
Table 1
Percentage steatosis in training and test sets, as
determined by the on-service pathologist.
Training set Test set
% steatosis N % of set N % of set
<5% 7 23 32 48
533% 10 33 15 2
3466% 9 30 12 18
>66% 4 13 7 11
Total 30 100 66 100
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entropic capacity increased at each phase. Prior exploration indicated
this set of training parameters prevented overfitting while yielding
satisfactory categorical accuracy.
The model was trained in a hold-one-out cross-validation scheme.
For each fold, the corresponding trained model was applied to the
withheld WSI by sampling image patches in a raster pattern from a
sliding window (832 £ 832-pixels) with a stride of 448 pixels, yield-
ing a 26 £ 26-pixel categorical probability map associated with each
respective image patch. These patches were stitched together to yield
a categorical probability map of the complete WSI, downsampled by
a factor of 32.
All WSI image analyses were performed using an Nvidia Tesla
K20X graphics processing unit (GPU).
Evaluation of pixel predictions
Evaluation of model performance was computed at several
stages of the modeling process. An annotation-based evaluation of
steatosis fraction was derived from CNN-generated pixel maps by
computing the sum of the steatosis probability from all pixels and
dividing by the area of the downsampled image associated with tis-
sue (determined from intensity thresholding). In the test sets, model
estimates were computed for both the bounding box area as well as
the whole slide. This value was compared to the corresponding
value derived from the annotation maps to compute Pearson’s cor-
relation coefficient, and intraclass correlation coefficient (ICC).
Statistics
Correlations and agreement measures between pathologist inter-
pretation of frozen section and FFPE histology, pathologist annotation
and CNN prediction, as well as CNN prediction and pathologist inter-
pretation of FFPE histology were performed by using the Pearson
correlation coefficient and ICC, respectively [50]. The intraclass corre-
lation coefficient is a statistical measure of rater agreement on the
same subjects, with values less than 0.5, 0.5 to 0.75, 0.75 to 0.9, and
>0.90 considered as poor, moderate, good and excellent agreement,
respectively [50,51]. The mean difference between evaluators was
compared using a linear mixed effects model. Statistical analyses
were performed using R, SPSS Statistics (IBM, Armonk, New York)
and GraphPad Prism v.8 (GraphPad Software, San Diego, California).
A p value of <0.05 was considered significant.
Materials availability statement
This study did not generate new unique reagents.
Ethics statement
The study was approved by the Institutional Review Board of
Washington University School of Medicine with a waiver of consent
(IRB number 201703119).
Results
Pathologist quantification of steatosis in donor liver biopsies may be
confounded by frozen section artifact and shows high inter-observer
variability
We retrieved 96 WSI with frozen and FFPE sections, correspond-
ing to 91 individual donors, evaluated by our institutional transplant
pathology service during a 20 month period. These cases exhibited a
wide range of macrovesicular steatosis. They were evaluated by
15 different on-service pathologists (OS-P), 6 of whomwere gastroin-
testinal/liver specialty pathologists. Each OS-P evaluated from 1 to
34 frozen sections, with an average of 6.6 cases and a median of 3
cases. To determine whether frozen section artifact may have
affected the OS-P estimates of steatosis, the slides were re-evaluated
by 3 pathologists who reviewed both the frozen section (available to
the OS-P at the time of their assessment), as well as the FFPE slides of
the frozen section remnants (not available to the OS-P). In addition,
the 3 pathologists had unconstrained time to examine the slides, and
performed their evaluation during their normal working hours,
whereas the OS-P assessed the frozen sections using current standard
of care, evaluating frozen section WSI at any time of the day or night,
with time pressure imposed by the urgent nature of these specimens.
The purpose of the re-review was to determine the discrepancy
between the on-service pathologist, faced with time constraints,
possible fatigue, and frozen section artifacts, and an “optimized”
pathologist assessment.
Inspection of the data demonstrated a few notable patterns,
including at the 30% threshold associated with poor graft survival
[17,20]. Of the 39WSI in which the average re-reviewer steatosis per-
centage was <5% (almost no steatosis), the OS-P overestimated stea-
tosis ( 5%) in 19 cases (49%) (Fig. 1a and Supplemental Table 1). The
OS-P reported steatosis 30% in 2 of these cases (5%) (Fig. 1a and Sup-
plemental Table 1). Manual re-review of these cases suggested that
processing artifact seen in the frozen sections, but not the FFPE sec-
tions, may have resulted in the higher OS-P estimate (example shown
in Fig. 2). In addition, for the 31 cases in which the average re-
reviewer steatosis percentage was >30%, the OS-P underestimated
steatosis (<30%) in 14 cases (45%) (Fig. 1a and Supplemental Table 1).
Manual re-review of these cases did not suggest any evident reasons
for the discrepancies.
Fig. 1. Pathologist quantification of steatosis in donor liver biopsies shows high inter-observer variability. a) Plot with linear regression of estimates of % steatosis by on-ser-
vice pathologists onWSI of frozen donor liver biopsies versus re-reviewer estimates (the average of estimates from 3 pathologists who had reviewed the corresponding FFPE slides).
Each dot represents the percent steatosis estimated from oneWSI of a donor liver biopsy. N = 96 WSI. The dotted lines indicate the 30% threshold reported in the literature for organ
discard. r2 value = squared Pearson correlation coefficient. ICC = intraclass correlation coefficient. b) Heat map of ICC between each pair of pathologists for steatosis quantification for
96 WSI. P1, P2, and P3 were re-reviewers, and OS-P was the on-service pathologist. ICC between all pathologists was 0.74 (95% CI 0.670.80).
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To investigate interobserver agreement, the intraclass correlation
coefficient (ICC) and Pearson correlation coefficient of percent steato-
sis values was calculated between each pair of pathologists, including
the 3 re-reviewers (P1, P2, and P3), and OS-Ps (Fig. 1b). Pearson cor-
relation coefficients between each pair ranged from 0.63 (P3 vs OS-P)
to 0.97 (P1 vs P3). ICC between each pair ranged from 0.59 to 0.96.
Although the degree of correlation between the 3 pathologists with
optimized assessment were, on average, higher than those for the
OS-Ps, variation still existed between individuals. The observed val-
ues are comparable to those previously reported in the literature
regarding frozen vs. FFPE liver sections, and between pathologists
[25,31,32].
Deep learning algorithm predictions of steatosis correlate with
annotations
To tackle the task of reproducibly quantifying donor liver biopsy
steatosis, taking into account frozen section artifact, a deep learning
algorithm/model was designed. The model was constructed using the
pre-trained VGG16 architecture, which was trained on millions of
high-resolution internet images [48]. The use of a pre-trained net-
work as a starting point, referred to as transfer learning, is commonly
used to reduce the need for large training datasets and decrease
training time[47]. The VGG16 convolutional layers and pretrained
weights were utilized as an initial framework, with the original fully-
connected layers replaced by a set of fully-convolutional upper layers
(Fig. 3). The model received WSI as input, processed the image via
layers of computations, and produced an output consisting of steato-
sis probabilities mapped to the input image. It then calculated the
percent steatosis from these probabilities. The model first had to be
trained to “recognize” areas of steatosis on a set of training images. It
was then tested for its performance on the training images again, as
well as de novo test images.
Our initially retrieved 96 WSI were divided into a training set
(n = 30 WSI) and a test set (n = 66 WSI), corresponding to 91 liver
donors (Table 1). As “ground truth,” for the model to recognize stea-
tosis, instead of visual estimation of percent steatosis, the WSI were
manually annotated by 2 pathologists for steatotic cells and steatotic
areas. All cells with macrovesicular steatosis were annotated. Inclu-
sion of the surrounding cell in the annotation of fat droplets ensured
that this information was presented to the model as meaningful input
for positive steatosis labeling, as opposed to voids arising from
random freezing artifact. Annotations were performed on the frozen
section WSI serially by two pathologists who had also seen the FFPE
permanent slides, to account for frozen artifact. This yielded 10,653
annotation areas comprising 75,079,680 pixel training targets.
The 30 annotated training images were presented to the model in
a hold-one-out cross validation scheme, in which the CNN was
trained using all images but one, which was then used to validate the
resulting model prediction. This was done in turn for all 30 training
images. This cross validation decreases overfitting and enables check-
ing of the model performance during the training phase. Probability
maps for the holdout slides indicating areas of steatosis were gener-
ated to compare model performance with manual annotations and
H&E slide images (Fig. 4). The model was able to predict areas of stea-
tosis, while ignoring other white areas on the slide, such as dilated
sinusoids and tears in the tissue.
A percent steatosis value was calculated from model-generated
pixel maps by summation of the steatosis probability from all pixels
and dividing by total area of tissue. At the WSI level, the model pre-
diction of percent steatosis for each WSI had good correlation and
agreement with the annotation % steatosis, with an r of 0.88 (95% CI
0.750.94) and ICC of 0.88 (95% CI 0.750.94) (Fig. 5a). After training,
the model was able to rapidly analyze the WSI and calculate percent
steatosis within 57 min, using a 6 year-old GPU (Nvidia Tesla
K20X).
Once the training regimen and model architecture had been eval-
uated in the cross-validation scheme, the model was trained anew
using all 30 slides in a single group. The network weights were then
kept constant, and the model was subsequently tested with the 66
annotated test WSI, which it had not previously received as input.
The model prediction of percent steatosis for the entire WSI again
correlated well with the percent steatosis calculated from the anno-
tation, with an r of 0.85 (95% CI 0.770.91) and an ICC of 0.85 (95% CI
0.760.90) (Fig. 5b), indicating the architecture’s fitness for inference
on new data. The model, once trained, was completely deterministic,
yielding an identical result every time for the same input WSI, and
did not require additional annotation by the pathologist.
Deep learning model has superior performance in steatosis estimation
compared to pathologists
The average re-reviewer and OS-P steatosis estimates were com-
pared to the percent steatosis calculated from the annotations. The
Fig. 2. Frozen section preparation of liver biopsies result in histologic artifacts that may be confused with steatosis. Scanned whole slide images of a) an H&E-stained frozen
section of a liver biopsy with <5% steatosis demonstrating preparation artifact, and b) the corresponding H&E-stained formalin fixed and paraffin-embedded frozen section rem-
nant. Black scale bar = 100mm. c) Area in yellow box in A with artifactual white spaces mimicking steatosis highlighted in blue and annotated “A.” Scanned whole slide images of d)
an H&E-stained frozen section of a liver biopsy with 80% steatosis, and e) the corresponding H&E-stained formalin fixed and paraffin-embedded frozen section remnant. Black scale
bar = 100 mm. f) Area in yellow box in A with steatosis highlighted in red and annotated “S.”.
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OS-P, representing the current standard of care, had the lowest corre-
lation and agreement to the annotations, with an r of 0.52 (95% CI
0.200.74) and ICC of 0.52 (95% CI 0.200.74) for the training set,
and an r of 0.74 (95% CI 0.610.83) and ICC of 0.72 (95% CI
0.580.82) for the test set (Fig. 5). The average of the re-reviewer
estimates had an r of 0.78 (95% CI 0.580.89) and ICC of 0.75 (95% CI
0.550.87) for the training set, and an r of 0.87 (95% CI 0.790.92)
and ICC of 0.79 (95% CI 0.680.87) for the test set, compared to
the annotations. Overall, the deep learning model had better agree-
ment with the percent steatosis calculated from annotations than the
pathologists.
The difference between the percent steatosis by annotation and
by the pathologist or model was calculated for each WSI. The means
of these differences were compared using a linear mixed effects
model. There was no significant difference across the means for the
training set (p = 0.19). For the test set, there was a significant pairwise
difference between the mean difference for the model compared to
the OS-P (p = 0.001) and for the model compared to the average re-
reviewer (p=<0.0001). There was no significant pairwise difference
between the OS-P and the average re-reviewer. These analyses
show that the model had significantly superior agreement with the
annotations compared to the pathologists.
Deep learning model performance at the 30% threshold for steatosis
Some institutions report using a 30% steatosis cutoff for rejection
of donor livers, although this threshold varies by center. If the manual
annotation is used as the gold standard, the sensitivity of the deep
learning algorithm to detect steatosis >30% in the 96 annotated WSI
was 15/21=71.4%, with a specificity of 73/75=97.3%. The positive pre-
dictive value (PPV) was 15/17=88.2%, and the negative predictive
value (NPV) was 73/79=92.4%. In contrast, the sensitivity and specific-
ity of the OS-P to detect steatosis >30% was 17/21=80.9% and 64/
75=85.3%, respectively. The PPV and NPV of the OS-P were 17/
28=60.7% and 64/68=94.1%, respectively. While the deep learning
model had lower sensitivity than the OS-P for identifying a case with
>30% steatosis, it had much higher specificity. Overall, the deep
learning model incorrectly classified 2 WSI as >30% compared to 11
WSI by the OS-P. Functionally, if a 30% steatosis cutoff were used as a
threshold for organ discard, the deep learning model would result in
Fig. 3. Schematic of fully convolutional neural network and steatosis fraction model. Each layer of the convolutional neural network is displayed as a 3-D box (red = max pool-
ing layer, blue = convolution+ReLU layer, green = softmax activation layer). A WSI was used as input and divided into partially-overlapping square image patches 832 pixels wide,
which were processed individually by the deep learning model. Output patches were stitched together to form steatosis probability maps. The VGG16 CNN base architecture was
employed, with weights frozen below the bottleneck (upper half of architecture). The fully-connected classification layers were replaced with 4 convolution+ReLu layers, with out-
put fed to a 2-node layer with softmax activation to classify each pixel into steatotic and non-steatotic categories. The percent steatosis for each WSI was calculated from the
model-generated pixel map by summation of the steatosis probabilities from all pixels divided by the total tissue area.
Fig. 4. Deep learning algorithm predictions of steatosis correlate with annota-
tions. Comparison of H&E-stained donor liver wedge biopsy (left column), mask of
annotated steatotic areas (black) within bounding boxes (green) (middle column), and
pixel-based model predictions of areas of steatosis across the WSI (grayscale probabil-
ity map, with 100% probability of steatosis in black, and 0% probability in white) (right
column). Black bar = 1 mm. Higher magnification insets shown in second row; black
bar = 0.5 mm.
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9/96=9% fewer organs unnecessarily discarded in this cohort, com-
pared to the current standard of care.
Discussion
We created a deep learning algorithm that is capable of identify-
ing and quantifying macrovesicular steatosis in WSI of donor liver
biopsy frozen sections. We validated our model on de novo whole
slide images, with performance superior to those of the current stan-
dard of care on-service pathologist evaluations and expert patholo-
gists in optimized evaluation conditions.
Our results were consistent with previously published reports
demonstrating inter-observer variability in quantifying percent
macrovesicular steatosis, and in differences between frozen section
and permanent section steatosis percentages [25,31,32]. We noted
specific instances in which pathologist overestimation on frozen
sectioning were most likely attributed to frozen preparation artifact.
The reasons for pathologist underestimation on frozen sectioning
were less evident. Some possibilities include an attempt to account
for frozen section artifact, misclassification of small droplet
macrosteatosis as microvesicular steatosis, or simple inaccuracy in
visual estimation.
To attempt to overcome inter-observer variability, there have
been multiple prior efforts to automate quantification of liver stea-
tosis [5257]. These methods usually measure steatosis by the frac-
tion/percent of the image area that is occupied by fat droplets.
Many use segmentation methods that focus on white space quantifi-
cation. These previous models cannot account for frozen section
artifact, while our model was designed to perform on frozen sec-
tions. We trained the algorithm on annotations that included only
areas of steatosis, not frozen artifactual white areas, which were
verified during annotation using the corresponding FFPE permanent
sections. We used annotation masks that included information sur-
rounding the white space, such as nuclei and cytoplasm, reasoning
that this contextual information could provide the deep learning
model with additional cues for classification. While this study did
not identify the pertinent features that the algorithm used to clas-
sify an area as steatotic, future studies could attempt to discover
these features through identification of activated regions of the
image after each convolution [58]. Notably, our model removes
intra-observer variability, as it is fully reproducible, producing the
same percent steatosis for a given WSI. We speculate that being
able to accurately and precisely assess percent steatosis with our
deep learning model could allow for the determination of clinically
useful steatotic thresholds for predicting graft outcome, instead of
the contested 30% cutoff. To accomplish this, our model could be
tested on larger datasets with WSI and clinical outcomes. Further
models combining this unbiased measurement of steatosis with
additional clinical factors and risk scores could facilitate optimal
allocation of the limited donor livers [59,60].
Our method directly modeled a pixel-based prediction of steatosis
to manual annotations, which are arguably a more objective measure
of steatosis than pathologist visual estimates. However, manual
annotation of images for training and testing is time and labor-inten-
sive. The use of representative bounding boxes for some WSI with
high amounts of steatosis, due to the labor intensiveness of annotat-
ing these slides, could also have affected the results. For future train-
ing and testing, computer-assisted semi-automated annotation of the
entire slide could be useful.
We designed our deep learning model as a fully convolutional
network that could rapidly process WSIs within 57 min, producing
a steatosis probability map registered pixel-wise to the input image,
and a resultant percent steatosis quantification. Because of memory
constraints, current GPU hardware cannot process an entire WSI
(typically 500 MB in size), requiring that an input image be subdi-
vided into “patches,” which are processed individually and stitched
together upon completion. In the naive CNN architecture, each input
patch is then assigned a label. We adapted this architecture by associ-
ating each input patch with an output patch, such that every output
pixel was associated with a label, rather than an entire patch. Thus,
although our number of WSI was relatively small, the amount of
input data was high, with greater than 10,000 annotation areas yield-
ing nearly 4 million pixel training targets, facilitating accurate train-
ing and prediction. Naïve CNN implementations that associate an
entire patch with a single label require far finer input image sampling
for equivalent output resolution, and can take far longer to produce a
result [41]. These technical innovations could be employed in other
histologic image analysis applications.
Our study was limited by the use of slides and images collected at
a single medical center, so the model performance may be weaker on
external datasets. The expansion of our dataset including the addition
of WSI from other institutions and pathology collections in our train-
ing and testing sets will be pursued as future research. It would also
be interesting to investigate whether annotation of non-steatotic
regions could be utilized as additional input to further refine our
deep learning model.
Fig. 5. Deep learning model performs superior to current standard of care in
assessing percent steatosis. a) Plot with linear regression of cross-validated model
prediction of percent steatosis compared to percent steatosis calculated from anno-
tated area in the training set. Each dot represents the percent steatosis for one WSI
(n = 30 WSI). b) Plot with linear regression of model prediction of percent steatosis
compared to percent steatosis calculated from annotated area in the test set (n = 66
WSI). c) Plot with linear regression of OS-P prediction of percent steatosis compared to
percent steatosis calculated from annotated area in the training set (n = 30 WSI). d)
Plot with linear regression of OS-P prediction of percent steatosis compared to percent
steatosis calculated from annotated area in the test set (n = 66 WSI). e) Plot with linear
regression of average re-reviewer prediction of percent steatosis compared to percent
steatosis calculated from annotated area in the training set (n = 30 WSI). f) Plot with
linear regression of average re-reviewer prediction of percent steatosis compared to
percent steatosis calculated from annotated area in the test set (n = 66 WSI). r2
value = squared Pearson correlation coefficient. ICC = intraclass correlation coefficient.
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The implementation of our model in a clinical setting would be in
an automated platform for quantification of steatosis in scanned
donor liver biopsy frozen sections, followed by pathologist verifica-
tion and quality assurance. Many pathology centers already routinely
use digital slide scanning for frozen intraoperative consultations and
donor biopsy evaluation [6163]. The deep learning model could be
hosted on an online application as a cloud computing service, such
that the user could upload the scanned WSI, run the assessment, and
receive the result within minutes. Pathologist evaluation of tissue
would still be necessary, both for quality control as well as for inter-
pretation of other histologic features, including fibrosis, necrosis, and
inflammation.
As the use of digital pathology and WSI expands, algorithms to
improve and facilitate pathologists’ diagnoses can be developed and
implemented. Computer-aided diagnosis for intraoperative consulta-
tions using frozen sectioning would be a highly useful application,
due to challenging frozen artifacts and the need for rapid evaluation.
Our deep learning model performed more accurately compared to
current standard of care on-call pathologists, and has the potential to
change the paradigm of donor liver examination. This model could
also be used in non-frozen section settings, as quantification of stea-
tosis is important in multiple other liver diseases. Our work further
advances this burgeoning field of histopathologic image analysis
using deep learning algorithms.
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